Navigation Links
Hospira to Present at Cowen and Company's 29th Annual Health Care Conference March 17
Date:3/10/2009

LAKE FOREST, Ill., March 10 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that the company will present at Cowen and Company's 29th Annual Health Care Conference on Tuesday, March 17, 2009, at The Boston Marriott Copley Place in Boston.

The presentation is scheduled to begin at 11 a.m. Eastern time on Tuesday, March 17, 2009. It will be available to all interested parties through a live audiocast accessible via the investor relations section of Hospira's Web site at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper computer setup to receive the audiocast. The slides accompanying the presentation will be available on the Hospira Web site. A replay of the webcast will be available on the Hospira Web site approximately 24 hours after the live presentation.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Hospira Expands Board of Directors
2. Hospira Reports Fourth-Quarter and Full-Year 2008 Results
3. Hospiras Precedex(R) Phase IV Study Published in the Journal of the American Medical Association
4. Hospira to Host Conference Call for Fourth-Quarter 2008 Results and 2009 Projections
5. Hospira to Present at J.P. Morgans 27th Annual Healthcare Conference January 14
6. Hospira Names Ken Meyers to Lead Human Resources
7. Hospira Reports Third-Quarter 2008 Results
8. Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12
9. FDA Approves New Indication for Hospiras Precedex (Dexmedetomidine HCL) Injection
10. Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And Equipment
11. Hospira Reports Second-Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... (PRWEB) May 19, 2013 According ... Market Analysis and Forecast (2013 – 2018): By ... Defense, Industrial)); Technology (CCD, CMOS, Contact IS, Infrared, ... of image sensor market was $8.00 billion in ... in 2018, at an estimated CAGR of 3.84% ...
(Date:5/19/2013)... 19, 2013 The Pradaxa lawyers at ... was recently convened for hundreds of Pradaxa bleeding ... underway in U.S. District Court, Southern District of Illinois. ... on May 14th, the Conference addressed the status of ... during the Conference that Defendants submitted a list of ...
(Date:5/19/2013)... 19, 2013 Vegas Hotel Escapes, the ... to announce the launch it's all new vacation packages ... Grand on 5/19/2013. Consumers traveling to Las Vegas will ... available on VegasHotelEscapes.com's website. Travelers will be pleased to ... competitors price. , Vegas Hotel Escapes specializes in helping ...
(Date:5/19/2013)... IL (PRWEB) May 19, 2013 Beginning Wednesday, ... River Valley Blood Center (RRVBC) will feature “Hot Dog Wednesdays" ... Belvidere. RRVBC will provide hot dogs and all the ... ice-cold slushies each day throughout the summer. “Donors are our ... maintain a stable and adequate blood supply. This is ...
(Date:5/19/2013)... May 19, 2013 The legal team ... YazSideEffects.com in a concerted effort to connect women and ... birth control drugs Yaz, Yasmin & Ocella with the ... of information on the notorious birth control drugs as ... Pharmaceuticals. , Yaz, Yasmin & Ocella were very ...
Breaking Medicine News(10 mins):Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2
... fears of anxiety-ridden fathers are passed on to the ... As many as 65 women were studied by the ... at this conclusion. ,This increased the pain ... affect their immediate recovery and factors such as breastfeeding ...
... new research conducted by Derek Griffiths, Ph.D., professor of geriatric ... bladder// control is due to the reduced activity of the ... his findings in a recent issue of the Journal of ... (fMRI) technology. , He analyzed the brain activity ...
... In UK deaths due to heart disease is on the rise. ... problems//. ,Hence The National Council for Health and Clinical ... from heart disease with statins. ,It is estimate that ... heart problem in the next 10 years. ,The National ...
... Public Health are of the opinion that the decision by almost ... presence of West Nile Virus is not a feasible option. ... very recently developed tests. This means that screening donated blood to ... order to avoid future infections. But the point is that many ...
... Southampton General Hospital, studied the inflammatory response in occupational ... at studying the environmental risk of developing infections and ... ,Researchers found that the inflammatory response in Metal ... persons and an absence of an immune response shows ...
... the soil can be used to clean the land which ... to the University of York. The team led by the ... Isolated a bacterial micro- // organism in the soil in ... a source of nitrogen for growth. ,However, ...
Cached Medicine News:
(Date:5/17/2013)... 2013  Sony Biotechnology Inc. ("Sony") today announced the launch ... 130um sorting chip.  Sony will also be exhibiting its newly ... Cell Sorter, the EC800 flow cytometer, and new SP6800 Spectral ... which will be held at the San Diego ... , from May 20 - 22.  ...
(Date:5/17/2013)... , May 17, 2013  TechAtlas Group ... for their competitive landscape map for the Chronic ... over 90 international companies with drugs and devices ... CKD and its sequelae. (Logo:  ... , hypertension - renal denervation ...
(Date:5/17/2013)... Fuse Science, Inc. (OTCQB: DROP), ( www.fusescience.com ) ... new, patent-pending technologies poised to redefine how consumers receive energy, ... a business update teleconference and webcast for shareholders and the ... 4:30 PM ET. Fuse Science, Inc. CEO, ... and will be joined by Rubin Hanan ...
Breaking Medicine Technology:Sony Delivers New Technology for Science to CYTO 2013 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2
... 2011 ViroPharma Incorporated (Nasdaq: VPHM ) today ... ViroPharma, will present at the Citi 2011 Global Healthcare Conference ... conference is being held at the Hilton New York Hotel ... and chief financial officer, of ViroPharma, will present at the ...
... Feb. 28, 2011 Rock Creek Pharmaceuticals, a wholly ... CIGX ) has been notified by the Roskamp Institute ... review board (IRB) approval to conduct a three-month, multi-site ...  The study (referred to as the "Flint Study"), will ...
Cached Medicine Technology:ViroPharma to Participate in Two March Healthcare Conferences 2Roskamp Institute Obtains IRB Approval for Multi-Site Human Clinical Trial with Rock Creek Pharmaceutical RCP-006 Compound 2Roskamp Institute Obtains IRB Approval for Multi-Site Human Clinical Trial with Rock Creek Pharmaceutical RCP-006 Compound 3Roskamp Institute Obtains IRB Approval for Multi-Site Human Clinical Trial with Rock Creek Pharmaceutical RCP-006 Compound 4
Finesse II electrosurgical generator (100-120 VAC) utilizes a patented design that integrates the electrosurgical generator and smoke evacuation system into a single compact unit....
The Aaron 900 high frequency desiccator forever removes the need to go through a tedious multi-step process to change from low to high power....
Sabre 180 is a powerful niche generator....
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
Medicine Products: